Published in Science Immunology · View the paper (DOI)
Researchers found SARS-CoV-2-specific CD4+ and CD8+ T cells in COVID-19 patients and 2 uninfected controls, supporting the development of protective virus-specific T cells. The study suggests that these T cells can increase over time, especially for those with severe respiratory symptoms.
Coverage from 2 institutions